Cherington Charles
SEC insider (Form 3/4/5 filer). CIK 0001448698. 10% Owner at Ernexa Therapeutics Inc. (ERNA). 29 reported Form 4/5 transactions since Sep 2024; latest on Feb 10, 2026. Located in BOSTON, MA.
Companies Cherington Charles has filed insider reports for
- Ernexa Therapeutics Inc. (ERNA): 10% Owner
Cherington Charles
CIK: 0001448698
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Ernexa Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (29 total)
- Feb 10, 2026ERNA
Ernexa Therapeutics Inc.
PurchaseDirect4M shares at avg. $0.50$2.0M - Jun 9, 2025ERNA
Ernexa Therapeutics Inc.
PurchaseDirect21.2M shares at avg. $0.10$2.2M - Apr 2, 2025ERNA
Eterna Therapeutics Inc.
PurchaseDirect3.8M shares at avg. $0.10$394K - Oct 29, 2024ERNA
Eterna Therapeutics Inc.
ConversionDirect2.8M shares at avg. $0.50$1.4M - Oct 29, 2024ERNA
Eterna Therapeutics Inc.
PurchaseDirect5.4M shares- - Oct 29, 2024ERNA
Eterna Therapeutics Inc.
PurchaseDirect1.2M shares- - Oct 29, 2024ERNA
Eterna Therapeutics Inc.
PurchaseDirect1.6M shares- - Oct 29, 2024ERNA
Eterna Therapeutics Inc.
PurchaseDirect261.8K shares- - Oct 29, 2024ERNA
Eterna Therapeutics Inc.
PurchaseDirect4.8M shares- - Oct 29, 2024ERNA
Eterna Therapeutics Inc.
SaleDirect12.0% Senior Convertible Notes due December 12, 2028
0 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 10, 2026 | ERNA Ernexa Therapeutics Inc. | Purchase | 4,000,000 | $0.50 | $2,000,000 | Direct |
| Jun 9, 2025 | ERNA Ernexa Therapeutics Inc. | Purchase | 21,241,163 | $0.10 | $2,221,826 | Direct |
| Apr 2, 2025 | ERNA Eterna Therapeutics Inc. | Purchase | 3,768,397 | $0.10 | $394,174 | Direct |
| Oct 29, 2024 | ERNA Eterna Therapeutics Inc. | Conversion | 2,819,546 | $0.50 | $1,409,773 | Direct |
| Oct 29, 2024 | ERNA Eterna Therapeutics Inc. | Purchase | 5,420,823 | - | $0 | Direct |
| Oct 29, 2024 | ERNA Eterna Therapeutics Inc. | Purchase | 1,237,762 | - | $0 | Direct |
| Oct 29, 2024 | ERNA Eterna Therapeutics Inc. | Purchase | 1,562,988 | - | $0 | Direct |
| Oct 29, 2024 | ERNA Eterna Therapeutics Inc. | Purchase | 261,756 | - | $0 | Direct |
| Oct 29, 2024 | ERNA Eterna Therapeutics Inc. | Purchase | 4,768,783 | - | $0 | Direct |
| Oct 29, 2024 | ERNA Eterna Therapeutics Inc. | Sale 12.0% Senior Convertible Notes due December 12, 2028 | 0 | - | - | Direct |
1-10 of 29 transactions